Keefe, Bruyette & Woods Reiterates Outperform on CME Group (CME)

Keefe, Bruyette & Woods is out with a research report this morning, where it reiterates its Outperform rating on CME Group Inc. CME; it has a $345.00 price target on the stock. The KBW analysts said that, after spending some time with company management, namely CEO of CME Group, Craig Donohue, they came away more confident in their expectation that CME's market structure may not change and that the move toward capital distribution does not signal an end to growth, rather an end to the capital-intensive deal growth. CME Group, Inc. is the largest and most diversified derivatives exchange in the U.S. Its products are traded in over 70 countries 23 hours per day through its open outcry and Globex trading platforms. CME's product diversity positions it well for growth through different economic cycles.